Specifically, zinc oxide nanostructures were used as a platform for conjugating monoclonal antibodies targeting the CD5 surface molecule and were tested as a photo-electrochemical immunosensor in T-ALL. The gene discussed is CD5; the disease is acute lymphoblastic leukemia.